Clinical Trial Update: Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating immunotherapy with or without radiotherapy for MSI-H/dMMR locally advanced colorectal cancer; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer (MSI-H) | Phase 2 | Status: NOT_YET_RECRUITING